Literature DB >> 19724678

Loss of endogenous interleukin-12 activates survival signals in ultraviolet-exposed mouse skin and skin tumors.

Syed M Meeran1, Nandan Katiyar, Tripti Singh, Santosh K Katiyar.   

Abstract

Interleukin-12 (IL-12)-deficiency promotes photocarcinogenesis in mice; however, the molecular mechanisms underlying this effect have not been fully elucidated. Here, we report that long-term exposure to ultraviolet (UV) radiation resulted in enhancement of the levels of cell survival kinases, such as phosphatidylinositol 3-kinase (PI3K), Akt (Ser(473)), p-ERK1/2, and p-p38 in the skin of IL-12p40 knockout (IL-12 KO) mice compared with the skin of wild-type mice. UV-induced activation of nuclear factor-kappaB (NF-kappaB)/p65 in the skin of IL-12 KO mice was also more prominent. The levels of NF-kappaB-targeted proteins, such as proliferating cell nuclear antigen (PCNA), cyclooxygenase-2, cyclin D1, and inducible nitric oxide synthase, were higher in the UV-exposed skin of IL-12 KO mice than the UV-exposed skin of wild types. In short-term UV irradiation experiments, subcutaneous treatment of IL-12 KO mice with recombinant IL-12 (rIL-12) or topical treatment with oridonin, an inhibitor of NF-kappaB, resulted in the inhibition of UV-induced increases in the levels of PCNA, cyclin D1, and NF-kappaB compared with non-rIL-12- or non-oridonin-treated IL-12 KO mice. UV-induced skin tumors of IL-12 KO mice had higher levels of PI3K, p-Akt (Ser(473)), p-ERK1/2, p-p38, NF-kappaB, and PCNA and fewer apoptotic cells than skin tumors of wild types. Together, these data suggest that the loss of endogenous IL-12 activates survival signals in UV-exposed skin and that may lead to the enhanced photocarcinogenesis in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724678      PMCID: PMC2735800          DOI: 10.1593/neo.09528

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  34 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Phosphoinositide kinases.

Authors:  C L Carpenter; L C Cantley
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 3.  Activation of mammalian gene expression by the UV component of sunlight--from models to reality.

Authors:  R M Tyrrell
Journal:  Bioessays       Date:  1996-02       Impact factor: 4.345

4.  NF-kappa B: ten years after.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1996-10-04       Impact factor: 41.582

Review 5.  Mechanisms and consequences of activation of protein kinase B/Akt.

Authors:  J Downward
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

Review 6.  NF-kappa B: a lesson in family values.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

Review 7.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

Authors:  G Trinchieri
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

8.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Authors:  R C Bargou; F Emmerich; D Krappmann; K Bommert; M Y Mapara; W Arnold; H D Royer; E Grinstein; A Greiner; C Scheidereit; B Dörken
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

9.  Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness.

Authors:  M F McCarty
Journal:  Med Hypotheses       Date:  1998-06       Impact factor: 1.538

10.  Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

Authors:  M J Brunda; L Luistro; R R Warrier; R B Wright; B R Hubbard; M Murphy; S F Wolf; M K Gately
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  9 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E₂ and prostaglandin E₂ receptors.

Authors:  Tripti Singh; Mudit Vaid; Nandan Katiyar; Samriti Sharma; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2010-10-25       Impact factor: 4.944

3.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Ultraviolet B light-induced nitric oxide/peroxynitrite imbalance in keratinocytes--implications for apoptosis and necrosis.

Authors:  Shiyong Wu; Lei Wang; Adam M Jacoby; Krystian Jasinski; Ruslan Kubant; Tadeusz Malinski
Journal:  Photochem Photobiol       Date:  2010-01-13       Impact factor: 3.421

6.  Grape seed proanthocyanidins inhibit melanoma cell invasiveness by reduction of PGE2 synthesis and reversal of epithelial-to-mesenchymal transition.

Authors:  Mudit Vaid; Tripti Singh; Santosh K Katiyar
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

7.  Grape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transition.

Authors:  Qian Sun; Ram Prasad; Eben Rosenthal; Santosh K Katiyar
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

8.  Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation.

Authors:  Young Kim; Yu-Ying He
Journal:  Genes Dis       Date:  2014-12-01

9.  Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis.

Authors:  Ki Mo Kim; A-Rang Im; Seung Hyung Kim; Jin Won Hyun; Sungwook Chae
Journal:  Cancer Sci       Date:  2016-01-22       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.